Free Trial

Commerzbank Aktiengesellschaft FI Purchases 3,322 Shares of Xylem Inc. (NYSE:XYL)

Xylem logo with Business Services background

Commerzbank Aktiengesellschaft FI raised its holdings in shares of Xylem Inc. (NYSE:XYL - Free Report) by 3.8% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 89,956 shares of the industrial products company's stock after acquiring an additional 3,322 shares during the quarter. Commerzbank Aktiengesellschaft FI's holdings in Xylem were worth $10,437,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. State Street Corp increased its stake in Xylem by 1.9% in the third quarter. State Street Corp now owns 10,329,494 shares of the industrial products company's stock valued at $1,394,792,000 after purchasing an additional 189,820 shares during the period. Geode Capital Management LLC grew its stake in Xylem by 1.0% in the 3rd quarter. Geode Capital Management LLC now owns 5,668,755 shares of the industrial products company's stock valued at $762,804,000 after acquiring an additional 54,877 shares during the last quarter. Impax Asset Management Group plc increased its stake in shares of Xylem by 231.5% during the 4th quarter. Impax Asset Management Group plc now owns 5,561,661 shares of the industrial products company's stock worth $644,039,000 after purchasing an additional 3,883,845 shares in the last quarter. Swedbank AB lifted its position in shares of Xylem by 23.1% in the fourth quarter. Swedbank AB now owns 3,683,201 shares of the industrial products company's stock valued at $427,325,000 after acquiring an additional 691,618 shares in the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its position in Xylem by 1.0% during the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 3,449,307 shares of the industrial products company's stock worth $465,760,000 after acquiring an additional 32,645 shares during the last quarter. Institutional investors and hedge funds own 87.96% of the company's stock.

Xylem Trading Down 0.3 %

Shares of Xylem stock traded down $0.40 on Thursday, hitting $129.27. 279,473 shares of the company's stock traded hands, compared to its average volume of 1,194,122. The company has a debt-to-equity ratio of 0.19, a current ratio of 1.76 and a quick ratio of 1.33. Xylem Inc. has a one year low of $113.26 and a one year high of $146.08. The stock has a market capitalization of $31.41 billion, a PE ratio of 35.40, a price-to-earnings-growth ratio of 2.33 and a beta of 1.07. The firm's 50-day moving average price is $123.29 and its two-hundred day moving average price is $127.10.

Xylem (NYSE:XYL - Get Free Report) last posted its quarterly earnings data on Tuesday, February 4th. The industrial products company reported $1.18 earnings per share for the quarter, topping the consensus estimate of $1.12 by $0.06. Xylem had a return on equity of 9.96% and a net margin of 10.40%. The company had revenue of $2.30 billion during the quarter, compared to analysts' expectations of $2.18 billion. During the same period in the prior year, the firm earned $0.99 earnings per share. Xylem's revenue for the quarter was up 8.6% compared to the same quarter last year. On average, research analysts expect that Xylem Inc. will post 4.65 EPS for the current fiscal year.

Xylem Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, March 19th. Stockholders of record on Tuesday, February 18th will be given a $0.40 dividend. This is an increase from Xylem's previous quarterly dividend of $0.36. The ex-dividend date of this dividend is Tuesday, February 18th. This represents a $1.60 annualized dividend and a dividend yield of 1.24%. Xylem's dividend payout ratio is presently 43.72%.

Analyst Ratings Changes

A number of brokerages have weighed in on XYL. Citigroup lowered shares of Xylem from a "strong-buy" rating to a "hold" rating in a report on Wednesday, February 5th. Stifel Nicolaus dropped their target price on shares of Xylem from $166.00 to $150.00 and set a "buy" rating for the company in a research report on Friday, January 24th. Robert W. Baird lifted their target price on Xylem from $139.00 to $148.00 and gave the company an "outperform" rating in a research note on Wednesday, February 5th. Wolfe Research restated a "peer perform" rating on shares of Xylem in a research report on Thursday, December 12th. Finally, TD Cowen dropped their price target on shares of Xylem from $138.00 to $125.00 and set a "hold" rating on the stock in a research report on Wednesday, November 6th. Four equities research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. According to MarketBeat.com, the company has an average rating of "Moderate Buy" and an average price target of $149.90.

Read Our Latest Report on XYL

Xylem Company Profile

(Free Report)

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.

See Also

Institutional Ownership by Quarter for Xylem (NYSE:XYL)

Should You Invest $1,000 in Xylem Right Now?

Before you consider Xylem, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Xylem wasn't on the list.

While Xylem currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

3 AI Stocks to Watch After NVIDIA’s Dip

3 AI Stocks to Watch After NVIDIA’s Dip

NVIDIA may be down, but the AI boom isn’t slowing anytime soon! While investors react to short-term price swings, smart money is looking at three stocks that could benefit from NVIDIA’s continued domi

Related Videos

5 Stocks to BUY NOW in March 2025
NVIDIA Revenue SOARS 78%, But Volatility Won’t STOP!
NVIDIA Earnings: Will it Spark a Rally or Trigger a Sell-Off?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines